Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2016-10-11 | New | $150,000,000 | $150,000,000 | Debt Only | 06b | SEC link |
| 2013-01-10 | New | $175,000,000 | $175,000,000 | Debt Only | 06 | SEC link |
| 2009-11-17 | New | $15,000,018 | Unknown | Equity Only | 06 | SEC link |
| 2009-09-03 | Amended | $249,996 | Unknown | Equity Only | 06 | SEC link |
| 2009-09-03 | New | $24,999,996 | Unknown | Equity Only | 06 | SEC link |
| 2009-08-31 | New | $249,996 | Unknown | Equity Only | 06 | SEC link |
| 2008-09-26 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| George H. Conrades | Director |
| Joseph C. Cook, Jr. | Director |
| Mark G. Currie | Executive |
| Andrew Dreyfus | Director |
| David A. Ebersman | Director |
| Marsha H. Fanucci | Director |
| Halley E. Giblert | Executive |
| Thomas Graney | Executive |
| Peter M. Hecht | Director, Executive |
| Michael J. Higgins | Executive |
| Stephen Knight | Director |
| Thomas A. Mccourt | Executive |
| Terrance G. Mcguire | Director |
| Julie H. Mchugh | Director |
| Gina Bornino Miller | Director |
| Lawrence S. Olanoff | Director |
| Edward P. Owens | Director |
| Bryan E. Roberts | Director |
| David E. Shaw | Director |
| Christopher T. Walsh | Director |
| Douglas E. Williams | Director |